Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions

Release Date: December 2017

Recommendation Summary

PopulationRecommendationGrade
(What's This?)
Postmenopausal women

The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women.

D
Postmenopausal women who have had a hysterectomy

The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal women who have had a hysterectomy.

D

To read the recommendation statement in JAMA, select here.

To read the evidence summary in JAMA, select here.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: December 2017

Internet Citation: Final Update Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions . U.S. Preventive Services Task Force. December 2017.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/menopausal-hormone-therapy-preventive-medication1

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857